Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Arbutus Will Cease Discovery Efforts And Discontinue Its IM-prove 3 Clinical Trial To Focus On Imdusiran And AB-101, The Company Will Reduce Its Workforce By 40% Incur One-time Restructuring Charge Of Approximately $3M-$4M To Be Recorded In Q3 Of 2024

Author: Benzinga Newsdesk | August 01, 2024 07:35am

With These Organizational Changes And Its Ongoing Cost Management Efforts, The Company Now Expects Its Current Cash, Cash Equivalents And Investments In Marketable Securities Will Be Sufficient To Fund Operations Into The Fourth Quarter Of 2026.

LNP Litigation Update

  • Next steps in the lawsuit against Moderna include expert reports and expert depositions. A trial date has been set for April 21, 2025, and is subject to change.
  • The lawsuit against Pfizer/BioNTech is ongoing and a date for a claim construction hearing has not been set.  

Posted In: ABUS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist